Latest Insider Transactions at Intercept Pharmaceuticals, Inc. (ICPT)
This section provides a real-time view of insider transactions for Intercept Pharmaceuticals, Inc. (ICPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERCEPT PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERCEPT PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2022
|
Jerome Benedict Durso CEO |
BUY
Grant, award, or other acquisition
|
Direct |
35,700
+24.28%
|
-
|
|
Jan 27
2022
|
David A Ford Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,600
+18.85%
|
-
|
|
Jan 27
2022
|
Jared Freedberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
10,300
+15.88%
|
-
|
|
Jan 27
2022
|
Linda M Richardson EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,300
+22.93%
|
-
|
|
Jan 27
2022
|
Andrew Saik EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,300
+14.16%
|
-
|
|
Jan 27
2022
|
Rocco Venezia Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+17.69%
|
-
|
|
Jan 11
2022
|
Bryan Ball Chief Qual. Officer & SVP Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,455
-9.82%
|
$39,280
$16.83 P/Share
|
|
Jan 01
2022
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.44%
|
$5,344
$16.29 P/Share
|
|
Jan 01
2022
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.48%
|
$1,696
$16.29 P/Share
|
|
Jan 01
2022
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-0.27%
|
$560
$16.29 P/Share
|
|
Dec 31
2021
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
2,455
-7.69%
|
$39,280
$16.29 P/Share
|
|
Dec 31
2021
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,607
-6.87%
|
$89,712
$16.29 P/Share
|
|
Dec 31
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,606
-6.83%
|
$25,696
$16.29 P/Share
|
|
Dec 31
2021
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
515
-3.76%
|
$8,240
$16.29 P/Share
|
|
Dec 31
2021
|
Lisa De Francesco SVP, IR & Corp. Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
542
-5.0%
|
$8,672
$16.29 P/Share
|
|
Dec 31
2021
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-4.74%
|
$19,376
$16.29 P/Share
|
|
Nov 30
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-0.61%
|
$64,889
$17.21 P/Share
|
|
Nov 30
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+0.98%
|
$104,346
$17.21 P/Share
|
|
Nov 15
2021
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-0.67%
|
$2,907
$17.67 P/Share
|
|
Nov 12
2021
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.99%
|
$6,061
$19.04 P/Share
|
|
Oct 29
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-0.62%
|
$61,072
$16.86 P/Share
|
|
Oct 29
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+0.98%
|
$98,208
$16.86 P/Share
|
|
Oct 01
2021
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-0.35%
|
$4,335
$15.22 P/Share
|
|
Oct 01
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.39%
|
$1,380
$15.22 P/Share
|
|
Oct 01
2021
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30
-0.22%
|
$450
$15.22 P/Share
|
|
Sep 30
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,816
-0.62%
|
$53,424
$14.85 P/Share
|
|
Sep 30
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,136
+0.98%
|
$85,904
$14.85 P/Share
|
|
Sep 30
2021
|
Lisa De Francesco SVP, IR & Corp. Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-1.85%
|
$2,856
$14.85 P/Share
|
|
Sep 01
2021
|
Lisa De Francesco SVP, IR & Corp. Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-4.64%
|
$8,070
$15.05 P/Share
|
|
Sep 01
2021
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
820
-3.09%
|
$12,300
$15.05 P/Share
|
|
Sep 01
2021
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
524
-3.67%
|
$7,860
$15.05 P/Share
|
|
Aug 31
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-0.62%
|
$53,438
$14.91 P/Share
|
|
Aug 31
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+0.99%
|
$85,932
$14.91 P/Share
|
|
Aug 15
2021
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-0.64%
|
$2,394
$14.92 P/Share
|
|
Aug 12
2021
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.98%
|
$4,785
$15.28 P/Share
|
|
Jul 30
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-0.62%
|
$64,889
$17.28 P/Share
|
|
Jul 30
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+0.99%
|
$104,346
$17.28 P/Share
|
|
Jul 01
2021
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-0.35%
|
$5,780
$20.47 P/Share
|
|
Jul 01
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.39%
|
$1,840
$20.47 P/Share
|
|
Jul 01
2021
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30
-0.21%
|
$600
$20.47 P/Share
|
|
Jun 30
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,816
-0.62%
|
$72,504
$19.97 P/Share
|
|
Jun 30
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,136
+0.99%
|
$116,584
$19.97 P/Share
|
|
Jun 21
2021
|
Andrew Saik EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,156
+50.0%
|
-
|
|
Jun 14
2021
|
M Michelle Berrey President, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
67,118
+50.0%
|
-
|
|
May 28
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-0.63%
|
$61,072
$16.63 P/Share
|
|
May 28
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+1.0%
|
$98,208
$16.63 P/Share
|
|
May 27
2021
|
Srinivas Akkaraju Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+18.91%
|
-
|
|
May 27
2021
|
Luca Benatti Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+28.37%
|
-
|
|
May 27
2021
|
Daniel Bradbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+30.78%
|
-
|
|
May 27
2021
|
Dagmar Rosa Bjorkeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,543
+50.0%
|
-
|